Bulevirtide, sold under the brand name Hepcludex, is an antiviral medication for the treatment of chronic hepatitis D (in the presence of hepatitis B)...
14 KB (787 words) - 02:46, 12 October 2024
Medicines Agency approved the antiviral Hepcludex (bulevirtide) to treat hepatitis D. Bulevirtide binds and inactivates the sodium/bile acid cotransporter...
51 KB (6,021 words) - 01:29, 14 November 2024
then Merck Group Protease inhibitor FDA approved 2011 Withdrawn 2015 Bulevirtide Hepatitis D/B Sodium/bile acid cotransporter inactivator Cidofovir AIDS...
13 KB (513 words) - 11:02, 22 November 2024
J05AX25 Baloxavir marboxil J05AX26 Amenamevir J05AX27 Favipiravir J05AX28 Bulevirtide J05AX29 Fostemsavir J05AX31 Lenacapavir "ATC (Anatomical Therapeutic...
6 KB (538 words) - 04:59, 18 December 2023
antivirals (primarily J05, also S01AD and D06BB) Hepatitis C Hepatitis D Bulevirtide Picornavirus viral entry: Pleconaril†Anti-influenza agents Baloxavir...
26 KB (2,541 words) - 05:04, 4 January 2024